3828725

Synthesis of N-substituted quinazoline-4-amine and N 2,N 4 -disubstituted quinazoline-2,4-diamine derivatives as adenosine/guanosine nucleoside ribohydrolase inhibitors in trichomoniasis

Date
March 29, 2023

Trichomoniasis is one of the most common sexually transmitted diseases caused by the protozoan Trichomonas vaginalis. This protozoan is not able to synthesize purine and pyrimidine rings, hence it scaveages nucleosides from the host cells, and obtains nucleobases through salvage pathway enzymes. The purine-specific adenosine/guanosine nucleoside ribohydrolase (AGNH) enzyme is one of the enzymes the parasite uses to obtain the nucleobases. Therefore the inhibition of AGNH represents a focus for research regarding novel treatment. The goal is to synthesize a molecule with a sub micromolar IC50 value that can inhibit AGNH, hence preventing T. vaginalis from growing. Preliminary results had shown that analogs of quinazolin-2-amine inhibited AGNH with IC50 values of 6.5 μM, 6.8 μM and 46 μM. The structures of the quinazolin-2-amine analogs, were combined with the pyrimidine ring structure of adenine and guanine to design analogs. Primary amines were reacted with 4-chloroquinazoline and 2,4-dichloroquinazoline to obtain N-substituted quinazoline-4-amine and N-substituted 2-chloroquinazoline-4-amine derivatives respectively. N-substituted 2-chloroquinazoline-4-amines were further reacted with another primary amine resulting in N 2,N 4 -disubstituted quinazoline-2,4-diamine derivatives. The results from the IC50 values showed that the products with the presence of amine groups at the 2 and 4 positions better inhibited AGNH.

Related Products

Thumbnail for Synthesis and evaluation of biaryl compounds as inhibitors of nucleoside hydrolases to treat trichomoniasis
Synthesis and evaluation of biaryl compounds as inhibitors of nucleoside hydrolases to treat trichomoniasis
Trichomoniasis is the most prevalent non-viral sexually transmitted diseases. It is caused by the parasitic protozoan _Trichomonas vaginalis_. Current treatments use 5-nitroimidazoles to damage DNA residues, but due to increasing resistance over time, there is a need for a novel treatment. _T…
Thumbnail for Computational design of trichomonas vaginalis purine nucleoside hydrolase inhibitors | Poster Board #3260
Computational design of trichomonas vaginalis purine nucleoside hydrolase inhibitors | Poster Board #3260
Trichomoniasis is a non-viral sexually transmitted disease caused by infection with the protozoan parasite _Trichomonas vaginalis_. In recent years the parasite has evolved increasing resistance to its current treatment with 5-nitroimidazole drugs. _T…
Thumbnail for Concerted use of molecular modeling and parasitology to guide design of novel Trichomonas vaginalis nucleoside ribohydrolase inhibitors
Concerted use of molecular modeling and parasitology to guide design of novel Trichomonas vaginalis nucleoside ribohydrolase inhibitors
_Trichomonas vaginalis_ is a protozoan parasite that causes trichomoniasis, a sexually transmitted disease which may lead to harmful complications. Current treatment regimens rely on metronidazole or related 5-nitroimidazole compounds…
Thumbnail for Investigating a Novel method of dynthesizing alpha,alpha- difluoronitriles | Poster Board #674
Investigating a Novel method of dynthesizing alpha,alpha- difluoronitriles | Poster Board #674
The presence of a fluorine is common in biological molecules in pharmaceuticals and agrochemicals. Its importance stems from a variety of reasons including increasing metabolic stability and changing the lipophilicity as well as modifying the acidity and basicity of nearby functional groups…